A single-center, randomized, double-blind, placebo-controlled human trial to evaluate the effect of steamed Panax Ginseng extract on the improvement of blood glucose level

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003494

Enrollment

Registered

2019-02-12

Start date

2019-01-31

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Black ginseng(back ginseng, crystallized cellulose, lactose, silicon dioxide, Magnesium Stearate) or placebo(dextrin, crystallized cellulose, lactose, silicon dioxide, Magnesium S

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Adults aged 19 and over 2) If the following criteria apply - Those who have not taken diabetes treatment - Fasting venous blood plasma glucose concentration of 100 ~ 125mg / dL - Those with HbA1C of 5.7-6.4 - Those who fully understand the purpose of this study and agree to participate

Exclusion criteria

Exclusion criteria: 1) patients with type 1 diabetes, gestational diabetes, or type 2 diabetes 2) Those who are taking medication that can have a significant effect on blood glucose control within 1 month 3) Patients with the following underlying diseases: uncontrolled hypertension (systolic blood pressure> 160 mmHg and diastolic blood pressure> 100 mmHg even after taking hypertension medication), malignancy, tuberculosis, asthma, glaucoma, depression with psychotic symptoms, bipolar affective disorder , Schizophrenia, dementia, liver function value 3 times or more normal value, renal function 1.5 times or more in normal range 4) Anyone who is pregnant, is breastfeeding or has a pregnancy plan 5) Daily drinking or smoker more than 1pack per day 6) Those who have an irritable reaction to the test product 7) Those who are at risk of serious drug interactions due to concomitant medication 8) Those who have contraindications for taking medication or medicine mentally 9) Those who can not participate in the legally 10) If there is a possibility of non-cooperative attitude in this human body test, or if it is judged by the researcher

Design outcomes

Primary

Measure	Time frame
postprandial glucose	—

Secondary

Measure	Time frame
Fasting blood sugar;plasma lipid (LDL, HDL, Triglyceride);Insulin, C-peptide	—

Countries

Korea, Republic of

Contacts

Public ContactChung-Sik Cho

Dunsan Korean Medicine Hospital of Daejeon University

choo1o2@dju.kr+82-42-470-9135

Outcome results